Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease.

Autor: Yanagi H; Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Miki K; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan. miki.keisuke.pu@mail.hosp.go.jp., Koyama K; Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Miyamoto S; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Mihashi Y; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Nagata Y; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Hashimoto K; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Hashimoto H; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Fukai M; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Maekura T; Maekura Acupuncture Clinic, 6-13 Nyoidani, Minoh, Osaka, Japan., Yonezawa R; Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Sakaguchi S; Department of Clinical Laboratories, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Nii T; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Matsuki T; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Tsujino K; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan., Kida H; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.
Jazyk: angličtina
Zdroj: BMC pulmonary medicine [BMC Pulm Med] 2024 Oct 31; Vol. 24 (1), pp. 550. Date of Electronic Publication: 2024 Oct 31.
DOI: 10.1186/s12890-024-03312-2
Abstrakt: Background: In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ([Formula: see text] E -[Formula: see text] CO2 ) slope has been reported as a measure of exercise efficiency, but the oxygen uptake efficiency slope (OUES), i.e., the slope of oxygen uptake ([Formula: see text] O2 ) versus the logarithmically transformed [Formula: see text] E , has rarely been reported.
Methods: We hypothesized that the [Formula: see text] E -[Formula: see text] CO2 slope is more useful than OUES in clinical use for the pathophysiological evaluation of COPD. Then, we investigated the cardiopulmonary exercise testing parameters affecting each of these slopes in 122 patients with all Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD grades selected from our database.
Results: Compared with the GOLD I-II group (n = 51), peak [Formula: see text] O2 (p < 0.0001), OUES (p = 0.0161), [Formula: see text] E at peak exercise (p < 0.0001), and percutaneous oxygen saturation (SpO 2 ) at peak exercise (p = 0.0004) were significantly lower in the GOLD III-IV group (n = 71). The GOLD III-IV group was divided into two groups by the exertional decrease in SpO 2 from rest to peak exercise: 3% or less (the non-desaturation group: n = 23), or greater than 3% (the desaturation group: n = 48). OUES correlated only weakly with peak [Formula: see text] O2 , [Formula: see text] E at peak exercise, and the difference between inspired and expired mean O 2 concentrations (ΔF O2 ) at peak exercise, i.e., an indicator of oxygen consumption ability throughout the body, in the GOLD III-IV group with exertional hypoxemia. In contrast, the [Formula: see text] E -[Formula: see text] CO2 slope was significantly correlated with ΔF O2 at peak exercise, regardless of the COPD grade and exertional desaturation. Across all COPD stages, there was no correlation between the [Formula: see text] E -[Formula: see text] CO2 slope and [Formula: see text] E at peak exercise, and stepwise analysis identified peak [Formula: see text] O2 (p = 0.0345) and ΔF O2 (p < 0.0001) as variables with a greater effect on the [Formula: see text] E -[Formula: see text] CO2 slope.
Conclusions: The OUES may be less useful in advanced COPD with exertional hypoxemia. The [Formula: see text] E -[Formula: see text] CO2 slope, which is independent of [Formula: see text] E , focuses on oxygen consumption ability and exercise tolerance in COPD, regardless of the exertional hypoxemia level and COPD grade. Therefore, the [Formula: see text] E -[Formula: see text] CO2 slope might be useful in establishing or evaluating tailor-made therapies for individual patient's pathologies in COPD as an indicator focusing on oxygen consumption ability.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: